Shareholder Democracy
Why It MattersHow It Works

Bristol-Myers Squibb Company

BMY · New York Stock Exchange · Health Care

☆ Follow

Shareholder advocacy aimed at Bristol-Myers Squibb Company

2 recorded campaigns from 2 organizations.

  • Seventh Generation Interfaith Coalition for Responsible Investment · 2024

    Seventh Generation Interfaith Coalition for Responsible Investment at Bristol Myers Squibb

    Adopt a comprehensive human rights policy that addresses the right to health across the company's operations and suppliers.

    Source

  • PETA · 2019 · Filed a resolution

    Filed a forced-swim-test resolution at Bristol-Myers Squibb

    PETA asked BMS's board to adopt a policy against funding, conducting, or commissioning the forced swim test, an animal-behavior assay PETA argues is scientifically unreliable and inhumane. Vote outcome not confirmed in sources reviewed.

    Source

What shareholders voted on

From Bristol-Myers Squibb Company’s own filings with the SEC. Support is the share of votes cast for and against, so abstentions and broker non-votes are not counted in it.

2026

ItemKindAsked for bySupportOutcome
The shareholder proposal on the adoption of a board policy that the chairperson of the board be an independent directorShareholder proposal27.6%Failed
Advisory vote to approve the compensation of our named executive officersSay on pay95.3%Passed
Karen H. Vousden, Ph.DCompany proposal98.9%Passed
Deepak L. Bhatt, M.D., M.P.H., M.B.ACompany proposal98.9%Passed
Manuel Hidalgo Medina, M.D., Ph.DCompany proposal98.5%Passed
Julia A. Haller, M.DCompany proposal98.5%Passed
Vote to approve the Company’s 2026 stock award and incentive planCompany proposal95.8%Passed
Christopher S. Boerner, Ph.DCompany proposal95.2%Passed
The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for 2026Auditor96.4%Passed
Election of Phyllis R. YaleDirector99.4%Passed
Election of Michael R. McMullenDirector99%Passed
Election of Paula A. PriceDirector98.1%Passed
Election of Derica W. RiceDirector97.2%Passed
Election of Theodore R. SamuelsDirector96.9%Passed
Election of Peter J. ArduiniDirector96.9%Passed

2025

ItemKindAsked for bySupportOutcome
The shareholder proposal on a Request to Cease DEI EffortsShareholder proposal1.7%Failed
The shareholder proposal on Corporate Financial SustainabilityShareholder proposal1.2%Failed
Advisory vote to approve the compensation of our named executive officersSay on pay94%Passed
Karen H. Vousden, Ph.DCompany proposal99.6%Passed
Deepak L. Bhatt, M.D., M.P.H., M.B.ACompany proposal99.6%Passed
Manuel Hidalgo Medina, M.D., Ph.DCompany proposal99.3%Passed
Julia A. Haller, M.DCompany proposal99.3%Passed
Christopher S. Boerner, Ph.DCompany proposal92.8%Passed
The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for 2025Auditor96.7%Passed
Election of Michael R. McMullenDirector99.7%Passed
Election of Phyllis R. YaleDirector99.6%Passed
Election of Paula A. PriceDirector98.9%Passed
Election of Theodore R. SamuelsDirector98.5%Passed
Election of Peter J. ArduiniDirector98.4%Passed
Election of Derica W. RiceDirector96.9%Passed

2024

ItemKindAsked for bySupportOutcome
The shareholder proposal on Executive Retention of Significant StockShareholder proposal38.7%Failed
The shareholder proposal on the adoption of a Board policy that the Chairperson of the Board be an independent directorShareholder proposal31.8%Failed
Advisory vote to approve the compensation of our named executive officersSay on pay94.4%Passed
Manuel Hidalgo Medina, M.D., Ph.DCompany proposal99.4%Passed
Julia A. Haller, M.DCompany proposal99.3%Passed
Deepak L. Bhatt, M.D., M.P.HCompany proposal99.3%Passed
Phyllis R. YaleCompany proposal98.7%Passed
Karen H. Vousden, Ph.DCompany proposal97.8%Passed
Paula A. PriceCompany proposal97.8%Passed
Derica W. RiceCompany proposal96.5%Passed
Theodore R. SamuelsCompany proposal95.9%Passed
Christopher S. Boerner, Ph.DCompany proposal93.6%Passed
Peter J. ArduiniCompany proposal93.1%Passed
Approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to provide for the elimination or limitation of monetary liability of specified executive officers of the Company for breach of the duty of careCompany proposal84.7%Passed
The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for 2024Auditor97.4%Passed

2023

ItemKindAsked for bySupportOutcome
The shareholder proposal on the adoption of a Board policy that the Chairperson of the Board be an independent directorShareholder proposal31.8%Failed
The shareholder proposal on special shareholder meeting improvementShareholder proposal5.9%Failed
The shareholder proposal on workplace non-discrimination auditShareholder proposal1.6%Failed
Advisory vote to approve the compensation of our named executive officersSay on pay92.4%Passed
Deepak L. Bhatt, M.D., M.P.HCompany proposal99.4%Passed
Manuel Hidalgo Medina, M.D., Ph.DCompany proposal98.4%Passed
Julia A. Haller, M.DCompany proposal98.4%Passed
Karen H. Vousden, Ph.DCompany proposal97.3%Passed
Giovanni Caforio, M.DCompany proposal92.4%Passed
The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for 2023Auditor97%Passed
Election of Phyllis R. YaleDirector98.1%Passed
Election of Paula A. PriceDirector97.3%Passed
Election of Peter J. ArduiniDirector97.1%Passed
Election of Derica W. RiceDirector95.4%Passed
Election of Theodore R. SamuelsDirector94.8%Passed
Election of Gerald L. StorchDirector92.7%Passed

2022

ItemKindAsked for bySupportOutcome
The shareholder proposal on the adoption of a Board policy that the Chairperson of the Board be an independent directorShareholder proposal44.8%Failed
The shareholder proposal to lower the ownership threshold for special shareholder meetings to 10%Shareholder proposal34.5%Failed
Advisory vote to approve the compensation of our named executive officersSay on pay91.9%Passed
Manuel Hidalgo Medina, M.D., Ph.DCompany proposal99.5%Passed
Julia A. Haller, M.DCompany proposal99.3%Passed
Karen H. Vousden, Ph.DCompany proposal97.5%Passed
Giovanni Caforio, M.DCompany proposal93.2%Passed
The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for 2022Auditor97.1%Passed
Election of Phyllis R. YaleDirector98.6%Passed
Election of Peter J. ArduiniDirector97.5%Passed
Election of Gerald L. StorchDirector96.4%Passed
Election of Paula A. PriceDirector96.4%Passed
Election of Theodore R. SamuelsDirector96.1%Passed
Election of Derica W. RiceDirector94.7%Passed

2021

ItemKindAsked for bySupportOutcome
The shareholder proposal on the adoption of a Board policy that the Chairperson of the Board be an independent directorShareholder proposal44.6%Failed
The shareholder proposal on shareholder right to act by written consentShareholder proposal34.8%Failed
The shareholder proposal to lower the ownership threshold for special shareholder meetings to 10%Shareholder proposal32.6%Failed
Advisory vote to approve the compensation of our named executive officersSay on pay91.1%Passed
Julia A. Haller, M.DCompany proposal99.3%Passed
Approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to lower the ownership threshold for special shareholder meetings to 15%Company proposal98.3%Passed
Karen H. Vousden, Ph.DCompany proposal96.8%Passed
Approve the company’s 2021 Stock Award and Incentive PlanCompany proposal95.4%Passed
Giovanni Caforio, M.DCompany proposal92.6%Passed
The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for 2021Auditor96.2%Passed
Election of Derica W. RiceDirector99.2%Passed
Election of Phyllis R. YaleDirector98.5%Passed
Election of Paula A. PriceDirector98.3%Passed
Election of Peter J. ArduiniDirector96.6%Passed
Election of Gerald L. StorchDirector95.6%Passed
Election of Theodore R. SamuelsDirector95.5%Passed
Election of Michael W. BonneyDirector87.8%Passed

2019

ItemKindAsked for bySupportOutcome
The proposalCompany proposal76.1%Passed
Bristol-Myers Squibb's stockholders voted on a proposal to approve the adjournment of the Special Meeting if necessary to solicit additional proxies if there were not sufficient votes at the time of the Special Meeting, or any adjournment or postponement thereof, to approve the Stock IssuanceCompany proposal73.5%Passed

2018

ItemKindAsked for bySupportOutcome
The shareholder proposal to lower the share ownership threshold to call special shareholder meetingsShareholder proposal41.9%Failed
The shareholder proposal on annual report disclosing how risks related to public concern over drug pricing strategies are incorporated into incentive compensation plansShareholder proposal22.7%Failed
Advisory vote to approve the compensation of our named executive officersSay on pay95.6%Passed
Karen H. Vousden, Ph.DCompany proposal99.6%Passed
José Baselga, M.D., Ph.DCompany proposal99.4%Passed
Giovanni Caforio, M.DCompany proposal97%Passed
Vicki L. Sato, Ph.DCompany proposal96.6%Passed
The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for 2018Auditor96.6%Passed
Election of Matthew W. EmmensDirector99.4%Passed
Election of Dinesh C. PaliwalDirector98.6%Passed
Election of Gerald L. StorchDirector97.1%Passed
Election of Theodore R. SamuelsDirector97.1%Passed
Election of Peter J. ArduiniDirector97.1%Passed
Election of Robert J. BertoliniDirector97%Passed
Election of Alan J. LacyDirector96.9%Passed
Election of Michael GrobsteinDirector96.5%Passed

Proxy statements and vote results

Straight from Bristol-Myers Squibb Company’s own SEC filings. The proxy statement lists what shareholders were asked to vote on; the 8-K certifies how the vote went.

YearFilingFiled
2026Vote results2026-05-08
2026Proxy statement2026-03-25
2025Vote results2025-05-07
2025Proxy statement2025-03-26
2024Vote results2024-05-09
2024Proxy statement2024-03-28
2023Vote results2023-05-04
2023Proxy statement2023-03-23
2022Vote results2022-05-05
2022Proxy statement2022-03-24
2021Vote results2021-05-06
2021Proxy statement2021-03-25
2020Proxy statement2020-03-25
2019Vote results2019-05-30
2019Proxy statement2019-04-30
2019Vote results2019-04-12
2018Vote results2018-05-03
2018Proxy statement2018-03-22

Do you represent Bristol-Myers Squibb Company? Claim this profile to respond to the campaigns listed here.

← All companies